Benzinga | Oct 1, 2021 11:50AM EDT

Labcorp's At Home Collection Kit Gets EUA Nod For Combined COVID-19 and Flu Detection

* The FDA has granted Emergency Use Authorization (EUA) to Laboratory Corp of America Holdings's (NYSE:LH) combined home collection kit to detect COVID-19 and influenza A/B simultaneously in individuals as young as 2 years of age.

* The kit will be available at no upfront cost to those who meet clinical guidelines.

* Starting in early October, adults 18 and over, as well as parents and guardians of children 2-17 years of age, can request the combined collection kit online through Pixel by Labcorp.

* The home collection kit uses the Roche Holdings AG's (OTC:RHHBY) Cobas SARS-CoV-2 & influenza A/B Test on the Cobas 6800/8800 Systems.

* Related content: Benzinga's Full FDA Calendar.

* Price Action: LH stock is down 0.44% at $280.21 during the market session on the last check Friday.